Handheld Breath Biopsy Contract Awarded to Owlstone from U.S. DoD
Owlstone Medical, a global provider of Breath Biopsy, announced that it had won an award from the the U.S. Department of Defense (DoD).
Owlstone Medical, a global provider of Breath Biopsy, announced that it had won an award from the the U.S. Department of Defense (DoD).
Asuragen Inc. has launched a testing kit for research use that is designed to detect pathogenic variants in the CFTR gene that cause cystic fibrosis.
Routine use of the positive run control enables laboratories to meet their individualized quality control goals, including evaluation of reagent lot changes and new shipments.
IGeneX’s new BCA assays are simple and cost-effective tests that give either a positive or negative result for exposure to Borrelia spp.
Read MoreThe company will receive funding to provide the breath biopsy component of a research initiative designed to provide new insights into the mechanisms of response and nonresponse to treatment for seven immune-mediated diseases.
Read MorePositive and negative controls are designed to help laboratories deliver reliable MTB-RIF testing results.
Read MoreThe funding will enable Lophius to expand clinical performance data and finalize design of the assay for use on automated platforms.
Read MoreA study by Karolinska Institute researchers shows that an algorithm used in a mobile phone app can efficiently manage uncontrolled asthma.
Read MoreStudy subjects with uncontrolled asthma had substantially higher levels of local IL-26 in their airways, when compared with subjects with controlled asthma.
Read MoreAccess to innovative diagnostic solutions will contribute to the World Health Organization’s infectious disease elimination goals.
Read MoreThe panel is the first offering in a deep and broad pipeline of assays planned for QIAstat-Dx in the United States.
Read MoreThe study will collect breath samples from asthmatic patients and healthy controls to analyze breath-based biomarkers.
Read MoreThe BD Max MDR-TB panel has obtained the CE mark, supporting market launch in Europe.
Read MoreThe test uses genetic biomarkers to determine with high accuracy whether inhaled substances and chemicals that come into contact with the lungs are allergenic or not.
Read MoreAs soon as a baby is born, its immune system starts to change dramatically in response to the bacteria and viruses in its new environment. The study was made possible using new techniques of immune cell analysis.
Read MoreNew module expands molecular testing capabilities, increases productivity and flexibility for the laboratory.
Read MoreliTechGroup Molecular Diagnostics has launched a multiplex assay, the respiratory bacterial Elite MGB panel, for the diagnosis of bacterial respiratory infections.
Read MoreRunning on the company’s Panther Fusion system, the new assay detects adenovirus, human metapneumovirus, and rhinovirus.
Read More